UGT1A1 and colonic neoplasm: Of interest, the pretreatment of HT29 cells with either UGT1A siRNA or propofol significantly recovered the ability of colon cancer cells in producing ROS upon TSA treatment, and this recovery was compromised by NAC, which is a ROS scavenger (Figure 4B and 4C).